Falcon Investments invests in Ora Clinical, a leading Ophthalmology CRO
Junior Capital Supporting Vistria’s LBO
Falcon Investment Advisors ("Falcon") is pleased to announce an investment in Ora LLC (“Ora”, "Ora Clinical", or the “Company”), a fullservice ophthalmology-focused Contract Research Organization. Falcon led a junior capital investment in support of an acquisition by The Vistria Group, LP ("Vistria").
Ora is one of the world’s leading full-service ophthalmic drug and device development firms, offering pre-clinical, clinical, consulting and regulatory, and patient and site solutions. The Company supports a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market.
"Falcon is pleased to partner with Vistria and Ora on this next phase of the Company’s growth. Ora’s reputation as a leader in the ophthalmic clinic research space is supported by an exceptional track record and a highly tenured team. We look forward to supporting Vistria and Ora’s expansion efforts on their exciting journey ahead," said Jonathan Moses, a Managing Director at Falcon.
Falcon Offers High Value Solutions Across the Capital Structure
With offices in Boston and New York, Falcon has been a leading provider of private credit to the North American middle market for 24 years. Falcon has invested $5.7 billion of junior capital in over 135 investments. Falcon is a long-term, flexible partner to entrepreneurs, family-owned businesses, and sponsors, providing a less dilutive alternative to pure growth equity.
Falcon provides creative junior capital solutions backing both sponsored and non-sponsored companies. Securities can be structured as subordinated debt, holdco debt, preferred, and common equity. Falcon provides ongoing support with additional capital investments and delayed draw take-down structures. For more information or to refer an investment opportunity, please contact the Falcon Business Development Team below or visit www.falconinvestments.com.